Top Markets
#1 Black Phoenix Black Phoenix +823.38%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +26.27%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.33%
#4 Prom Prom +20.84%
#5 Beam Beam +20.03%
#6 SAFEcoin SAFEcoin +19.77%
#7 Magma Finance Magma Finance +19.58%
#8 Bless Bless +17.25%
#9 pipedog pipedog +16.97%
#10 YFSX YFSX +16.05%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
PT Kalbe Farma Tbk. PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.

KLBF
株式のランク #6215
PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its... PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its subsidiaries, focuses on the development, manufacturing, and commercialization of pharmaceutical products across Indonesia. Its operations are structured into four primary divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics. The company's diverse portfolio encompasses generic, branded, and licensed medications, including well-known names like Brainact, Cefspan, and Mycoral, which are supplied to hospitals, pharmacies, and various drugstores. Beyond prescription drugs, it offers non-prescription medicines, a range of energy and ready-to-drink beverages, dietary supplements, and other preventive health solutions. Kalbe Farma also produces specialized nutritional products tailored for all demographics, from infants to seniors, including expectant mothers and individuals with specific medical dietary needs. The firm extends contract services to other pharmaceutical companies, covering clinical study management, bioavailability/bioequivalence assessments, and analytical testing. Additionally, it provides animal health products and operates its own healthcare facilities, the Mitrasana Clinics. Its broad scope of activities further includes health screening, acting as an agent for biotechnology products, and the distribution of consumer items, medical devices, and cosmetics. The company also trades in medical and laboratory equipment and supplies, raw materials for pharmaceuticals, and consumables for hemodialysis therapy, in addition to offering advertising services. Founded in 1966, PT Kalbe Farma Tbk. is headquartered in Jakarta, Indonesia.
株価
$0.04784262
時価総額
$2.16B
変化（1日）
0.00%
変化（1年）
-39.38%
国
ID
取引 PT Kalbe Farma Tbk. (KLBF)

カテゴリー

Healthcare
PT Kalbe Farma Tbk.（KLBF）の利益
2026 時点の利益 TTM: 0
PT Kalbe Farma Tbk. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
PT Kalbe Farma Tbk. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US